Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, Joshua D., Li, Lu, Wang, Yuxuan, Thoburn, Christopher, Afsari, Bahman, Danilova, Ludmila, Douville, Christopher, Javed, Ammar A. +34 more·2018·Science

Cited by (1,003)

Items 401–500 of 1,003

  1. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA
    Christopher Pham Pacia, Jinyun Yuan, Yimei Yue, Lu Xu, Arash Nazeri, Rupen R. Desai, H. Michael Gach, Xiaowei Wang, Michael Talcott, Aadel A. Chaudhuri et al. · 2021 · Theranostics
  2. Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients
    Jie Ren, Ping Lü, Xin Zhou, Yuhan Liao, Xiaomeng Liu, Jingyi Li, Wendong Wang, Jilian Wang, Lu Wen, Wei Fu et al. · 2021 · Clinical Chemistry
  3. New Perspectives on the Importance of Cell-Free DNA Biology
    Abel Jacobus Bronkhorst, Vida Ungerer, Angela Oberhofer, Sophie Gabriel, Eleni Polatoglou, Hannah Randeu, Carsten Uhlig, Heiko Pfister, Zsuzsanna Mayer, Stefan Holdenrieder · 2022 · Diagnostics
  4. Circulating cell-free DNA-based multi-cancer early detection
    Kai Zhang, Ruiqing Fu, Rui Liu, Zhixi Su · 2023 · Trends in cancer
  5. A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
    Wei Liu, Jie Li, Ping Zhang, Qiaoyun Hou, Shi Feng, Lisheng Liu, Dawei Cui, Hubing Shi, Yan Fu, Yongzhang Luo · 2019 · Cancer Science
  6. Projected Reductions in Absolute Cancer–Related Deaths from Diagnosing Cancers Before Metastasis, 2006–2015
    Christina A. Clarke, Earl A. Hubbell, Allison W. Kurian, Graham A. Colditz, Anne‐Renee Hartman, Scarlett Lin Gomez · 2020 · Cancer Epidemiology Biomarkers & Prevention
  7. SequencErr: measuring and suppressing sequencer errors in next-generation sequencing data
    Eric M. Davis, Yu Tao Sun, Yanling Liu, Pandurang S. Kolekar, Ying Shao, Karol A. Szlachta, Heather L. Mulder, Dongren Ren, Stephen V. Rice, Zhaoming Wang et al. · 2021 · Genome biology
  8. A deep learning model for predicting next-generation sequencing depth from DNA sequence
    Jinny Xuemeng Zhang, Boyan Yordanov, Alexander L. Gaunt, Michael Wang, Peng Dai, Yuan-Jyue Chen, Kerou Zhang, John Z. Fang, Neil Dalchau, Jiaming Li et al. · 2021 · Nature Communications
  9. Development of electroactive materials-based immunosensor towards early-stage cancer detection
    Ziyu Li, Jiaqi Zhang, Yixuan Huang, Jinxia Zhai, Guangfu Liao, Zhengao Wang, Chengyun Ning · 2022 · Coordination Chemistry Reviews
  10. Integrative analysis of multi-omics data for liquid biopsy
    Geng Chen, Jing Zhang, Qiaoting Fu, Valérie Taly, Fei Tan · 2022 · British Journal of Cancer
  11. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
    Haifeng Shen, Yichen Jin, Heng Zhao, Manqi Wu, Kai Zhang, Zihan Wei, Xin Wang, Ziyang Wang, Yun Li, Fan Yang et al. · 2022 · BMC Medicine
  12. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
    Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani, Stefania Napolitano · 2023 · Exploration of Targeted Anti-tumor Therapy
  13. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
    Н. О. Туаева, Luca Falzone, Yuri B. Porozov, Alexander E. Nosyrev, В. М. Трухан, Leda Kovatsi, Demetrios A. Spandidos, Nikolaos Drakoulis, Alexandra M. Kalogeraki, Charalampos Mamoulakis et al. · 2019 · Cells
  14. Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area
    Marco Tognetti, Kamil Skłodowski, Sebastian Müller, Dominique Kamber, Jan Muntel, Roland Bruderer, Lukas Reiter · 2022 · Journal of Proteome Research
  15. Liquid biopsy into the clinics: Current evidence and future perspectives
    Myrto A Boukovala, Christoph Benedikt Westphalen, Victoria Probst · 2024 · The Journal of Liquid Biopsy
  16. Molecular Pathology of Lung Cancer
    James Joseph Saller, Theresa A. Boyle · 2021 · Cold Spring Harbor Perspectives in Medicine
  17. Isolation of circulating tumor cells
    Jon F., Avanish Mishra, Kyle C. Smith, Ravi Kapur, Shyamala Maheswaran, Daniel A. Haber, Mehmet Toner · 2022 · iScience
  18. Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
    Sijun Pan, Aixiang Ding, Yisi Li, Yaxin Sun, Yueqin Zhan, Zhenkun Ye, Ning Song, Bo Peng, Lin Li, Wei Huang et al. · 2023 · Chemical Society Reviews
  19. Optical nanomaterial-based detection of biomarkers in liquid biopsy
    Young Jun Kim, Won‐Yeop Rho, Seung-min Park, Bong‐Hyun Jun · 2024 · Journal of Hematology & Oncology
  20. The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins
    Kyriacos N. Felekkis, Christos P. Papaneophytou · 2024 · International Journal of Molecular Sciences
  21. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma
    Yi Qin, Chung Wah Wu, William R. Taylor, Tarek Sawas, Kelli N. Burger, Douglas W. Mahoney, Zhifu Sun, Tracy C. Yab, Graham P. Lidgard, Hatim T. Allawi et al. · 2019 · Clinical Cancer Research
  22. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction
    Jee-Soo Lee, Miyoung Kim, Moon‐Woo Seong, Han-Sung Kim, Young Kyung Lee, Hee Jung Kang · 2019 · Clinical Chemistry and Laboratory Medicine (CCLM)
  23. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Journal of Hematology & Oncology
  24. Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach
    Guillaume Le Cosquer, Charlotte Maulat, Barbara Bournet, Pierre Cordelier, Étienne Buscail, Louis Buscail · 2023 · Cancers
  25. Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
    Gisela Barbany, Cecilia Arthur, Agne Liedén, Magnus Nordenskjöld, Richard Rosenquist, Bianca Tesi, Karin Wallander, Emma Tham · 2019 · Journal of Internal Medicine
  26. Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors
    Maria Frances Coakley, Isaac García-Murillas, Nicholas C. Turner · 2019 · Clinical Cancer Research
  27. Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses
    Andrew C. Liu, Krishna Patel, Ramya Vunikili, Kipp W. Johnson, Fahad Abdu, Shivani Kamath Belman, Benjamin Scott Glicksberg, Pratyush P. Tandale, Roberto Fontanez, Oommen K. Mathew et al. · 2019 · Briefings in Bioinformatics
  28. Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies
    Breeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, Josiah T. Wagner, Rowan L. Callahan, Elias Spiliotopoulos, C. Ward Kirschbaum, Fehmi Çivitçi, Paul T. Spellman, Reid F. Thompson et al. · 2022 · npj Precision Oncology
  29. Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection
    Carmen E. Guerra, Prateek V. Sharma, Brenda Sofia Castillo · 2023 · Annual Review of Medicine
  30. Cancer screening with multicancer detection tests: A translational science review
    Wendy S. Rubinstein, Christos Patriotis, Anthony J. Dickherber, Paul K. J. Han, Hormuzd A. Katki, Elyse M LeeVan, Paul F. Pinsky, Philip C. Prorok, Amanda L. Skarlupka, Sarah Madhu Temkin et al. · 2024 · CA A Cancer Journal for Clinicians
  31. Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies
    Aoife Ward, Judith Lenhardt, Tania Witte, Denise Keitel, Anna Kaufhold, Kendra K. Maaß, Kristian W. Pajtler, Christof Sohn, Sarah Schott · 2019 · International Journal of Molecular Sciences
  32. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
    Óscar Rapado‐González, Blanca Majem, Ana Álvarez-Castro, Roberto Díaz‐Peña, Alicia Abalo, Leticia Suárez‐Cabrera, Antonio Gil‐Moreno, Anna Santamaría, Rafael López‐López, Laura Muinelo‐Romay et al. · 2019 · Journal of Clinical Medicine
  33. Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
    Uttam Satyal, Abhishek Srivastava, Philip H. Abbosh · 2019 · Frontiers in Oncology
  34. Next-Generation Liquid Biopsies: Embracing Data Science in Oncology
    Yu Ri Im, Dana W.Y. Tsui, Luis Alberto Diaz, Jonathan C. M. Wan · 2020 · Trends in cancer
  35. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
    Filippo Martignano, Uday Munagala, Stefania Crucitta, Alessandra Mingrino, Roberto Semeraro, Marzia Del Re, Iacopo Petrini, Alberto Magi, Silvestro Giovanni Conticello · 2021 · Molecular Cancer
  36. Point‐Of‐Care Ultra‐Portable Single‐Molecule Bioassays for One‐Health
    Eleonora Macchia, Fabrizio Torricelli, Mariapia Caputo, Lucia Sarcina, Cecilia Scandurra, Paolo Bollella, Michele Catacchio, Matteo Piscitelli, Cinzia Di Franco, Gaetano Scamarcio et al. · 2023 · Advanced Materials
  37. How to use liquid biopsies to treat patients with cancer
    Leticia De Mattos‐Arruda, Giulia Siravegna · 2021 · ESMO Open
  38. Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
    Kevin Chen, Misty Dawn Shields, Pradeep S. Chauhan, Ricardo J. Ramirez, Peter K. W. Harris, Melissa Andrea Reimers, Jose Pedro Zevallos, Andrew A. Davis, Bruna Pellini, Aadel A. Chaudhuri · 2021 · Molecular Diagnosis & Therapy
  39. Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification
    Hua Zhang, Lin Zhao, Jingjing Jiang, Jie Zheng, Li Yang, Yanyan Li, Jian Zhou, Tianshu Liu, Jianmin Xu, Wenhui Lou et al. · 2022 · Nature Communications
  40. Noninvasive detection of any-stage cancer using free glycosaminoglycans
    Siniša Bratulić, Angelo Limeta, Saeed Dabestani, Helgi Birgisson, Gunilla Enblad, Karin Stålberg, Göran Hesselager, Michael Häggman, Martin Höglund, Oscar E. Simonson et al. · 2022 · Proceedings of the National Academy of Sciences
  41. Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis
    Xiao Zhou, Zhen Cheng, Mingyu Dong, Qi Liu, Weiyang Yang, Min Liu, Junzhang Tian, Weibin Cheng · 2022 · Nature Communications
  42. Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives
    Nian‐Nian Zhong, Hanqi Wang, Xinyue Huang, Zi‐Zhan Li, Lei‐Ming Cao, Fang‐Yi Huo, Bing Liu, Lin‐Lin Bu · 2023 · Seminars in Cancer Biology
  43. Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
    Van Thien Chi Nguyen, Trong Hieu Nguyen, Nhu Nhat Tan Doan, Thi Mong Quynh Pham, Giang Thi Huong Nguyen, Thanh Dat Nguyen, Thuy Thi Thu Tran, Vo Duy Long, Thanh Hai Phan, Thanh Xuan Jasmine et al. · 2023 · eLife
  44. Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood
    Yuhuan Tao, Shaozhen Xing, Shuai Zuo, Pengfei Bao, Yunfan Jin, Yu Li, Mingyang Li, Yingchao Wu, Shanwen Chen, Xiaojuan Wang et al. · 2023 · Cell Reports Medicine
  45. Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer
    Xianyu Zhang, Weiwei Zhao, Wei Wei, Zilong You, Xiaohua Ou, Mingming Sun, Yanling Yin, Xiaoyan Tang, Zhen Zhao, Changming Hu et al. · 2019 · Clinical Cancer Research
  46. Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction
    Rebecca W.Y. Chan, Lee Serpas, Meng Ni, Stefano Volpi, Linda T. Hiraki, Lai‐Shan Tam, Ali Rashidfarrokhi, Priscilla C. H. Wong, Lydia H.P. Tam, Yueyang Wang et al. · 2020 · The American Journal of Human Genetics
  47. Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer
    Santonja, Angela, Cooper, Wendy N, Eldridge, Matthew D, Edwards, Paul A W, Morris, James A, Edwards, Abigail R, Zhao, Hui, Heider, Katrin, Couturier, Dominique‐Laurent, Vijayaraghavan, Aadhitthya et al. · 2023 · EMBO Molecular Medicine
  48. Predictive biomarkers for drug response in bladder cancer
    Takahiro Yoshida, Max R. Kates, Kazutoshi Fujita, Trinity Jude Bivalacqua, David James McConkey · 2019 · International Journal of Urology
  49. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
    Johann von Felden, Teresa García‐Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig, Stacey M. Gifford, Benjamin H. Wunsch, Joshua T. Smith, Sung‐Cheol Kim et al. · 2021 · Gut
  50. Clinical correlates of circulating cell-free DNA tumor fraction
    Joerg Bredno, Jafi Alyssa Lipson, Oliver Venn, Alexander M. Aravanis, Arash Jamshidi · 2021 · PLoS ONE
  51. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
    Karan Kumar Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente‐Cuomo, Havell Markus, Maria Farooq, Patricia Filippsen Favaro, Sydney C Connor, Sara Ann Byron, Jan B. Egan et al. · 2023 · Science Translational Medicine
  52. Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
    Derek Wong, Ping Luo, Leslie E. Oldfield, Haifan Gong, Ledia Brunga, Ron Rabinowicz, Vallijah Subasri, Clarissa F. Chan, Tiana Downs, Kirsten M. Farncombe et al. · 2023 · Cancer Discovery
  53. Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Jee-Soo Lee, Tae‐Min Rhee, Daniel Pietrasz, Jean‐Baptiste Bachet, Pierre Laurent‐Puig, Sun‐Young Kong, Erina Takai, Shinichi Yachida, Tatsuhiro Shibata, Jung Woo Lee et al. · 2019 · Scientific Reports
  54. Pushing the limits of electrochemistry toward challenging applications in clinical diagnosis, prognosis, and therapeutic action
    Paloma Yáñez‐Sedeño, Susana Campuzano, José Manuel Pingarrón · 2019 · Chemical Communications
  55. The Roadmap of Colorectal Cancer Screening
    Enea Ferlizza, Rossella Solmi, Michela Sgarzi, Luigi Ricciardiello, Mattia Lauriola · 2021 · Cancers
  56. Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing
    Ping Song, Sherry Xi Chen, Yan Helen Yan, Alessandro Pinto, Lauren Yuxuan Cheng, Peng Dai, Abhijit A. Patel, David Yu Zhang · 2021 · Nature Biomedical Engineering
  57. Recent advances in liquid biopsy technologies for cancer biomarker detection
    Narshone Soda, Kimberley Clack, Muhammad J. A. Shiddiky · 2022 · Sensors & Diagnostics
  58. Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    Sumanta Kumar Pal, Michael J. Miller, Neeraj Agarwal, Susan Marina Chang, Mariana Chávez‐MacGregor, Ezra E.W. Cohen, Suzanne Cole, William Dale, Catherine Diefenbach, Mary Lenora Disis et al. · 2019 · Journal of Clinical Oncology
  59. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
    Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, Joseph C. Maroon, Dominic P. D’Agostino, Adrienne C. Scheck, Angela M. Poff, Sebastian Friedrich Winter, Jethro Lisien Hu, Rainer J. Klement et al. · 2024 · BMC Medicine
  60. Current Approaches to Pancreatic Cancer Screening
    Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey A. Risch, James J. Farrell · 2018 · American Journal Of Pathology
  61. Machine Learning and Imaging Informatics in Oncology
    Tseng, Huan-Hsin, Wei, Lise, Cui, Sunan, Luo, Yi, Ten Haken, Randall K., El Naqa, Issam · 2020 · Oncology
  62. The Metastatic Cascade as the Basis for Liquid Biopsy Development
    Zahra Eslami‐S, Luis Enrique Cortés‐Hernández, Catherine Alix‐Panabières · 2020 · Frontiers in Oncology
  63. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
    Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel · 2020 · Cancers
  64. Multicancer Early Detection: Learning From the Past to Meet the Future
    Ruth Etzioni, Roman Gulati, Noel S. Weiss · 2021 · JNCI Journal of the National Cancer Institute
  65. Development and validation of a circulating microRNA panel for the early detection of breast cancer
    Ruiyang Zou, Sau Yeen Loke, Yew Chung Tang, Heng‐Phon Too, Lihan Zhou, Ann S. G. Lee, Mikael Hartman · 2022 · British Journal of Cancer
  66. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer
    Austin K. Mattox, Gypsyamber DʼSouza, Zubair Hanif Khan, Hailey Allen, Stephanie N. Henson, Tanguy Y. Seiwert, Wayne M. Koch, Drew M. Pardoll, Carole Fakhry · 2022 · Oral Oncology
  67. Electrochemical biosensing in oncology: a review advancements and prospects for cancer diagnosis
    Sana Noreen, Izwa Ishaq, Muhammad Hamzah Saleem, Baber Ali, Syed Muhammad Ali, Javed Iqbal · 2025 · Cancer Biology & Therapy
  68. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Mai‐Britt W. Ørntoft · 2018 · Clinical Colorectal Cancer
  69. Simple and Low‐Cost Sampling of Cell‐Free Nucleic Acids from Blood Plasma for Rapid and Sensitive Detection of Circulating Tumor DNA
    Choong Eun Jin, Bonhan Koo, Tae Yoon Lee, Kyudong Han, Seok‐Byung Lim, In Ja Park, Yong Moon Shin · 2018 · Advanced Science
  70. Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
    Michael A. Kiebish, Jennifer C. Cullen, Prachi Mishra, Amina Ali, Eric J. Milliman, Leonardo O. Rodrigues, Emily Y. Chen, Vladimir Tolstikov, Lixia Zhang, Kiki Panagopoulos et al. · 2020 · Journal of Translational Medicine
  71. The Translational Status of Cancer Liquid Biopsies
    Siniša Bratulić, Francesco Gatto, Jens Nielsen · 2019 · Regenerative Engineering and Translational Medicine
  72. Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?
    Jiayi Weng, Xiaoqiang Xiang, Ling‐Wen Ding, Andrea Li‐Ann Wong, Qi Zeng, Gautam Sethi, Lingzhi Wang, Soo Chin Lee, Boon Cher Goh · 2021 · Seminars in Cancer Biology
  73. Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA
    Jonathan C. M. Wan, Dennis P. Stephens, Lingqi Luo, James Robert White, Caitlin M. Stewart, Benoı̂t Rousseau, Dana W.Y. Tsui, Luis Alberto Diaz · 2022 · Nature Communications
  74. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
    Francesca Pezzuto, Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello · 2018 · International Journal of Molecular Sciences
  75. Refining Cancer Management Using Integrated Liquid Biopsy
    Juhui Qiu, Jianxiong Xu, Kang Zhang, Wei Gu, Liming Nie, Guixue Wang, Yang Luo · 2020 · Theranostics
  76. Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
    Anna Göthlin Eremo, Kajsa Lagergren, Lana Othman, Scott Montgomery, Göran Andersson, Elisabet Tina · 2020 · Scientific Reports
  77. Biomarkers for Gastric Cancer Screening and Early Diagnosis
    Cristina Herrera‐Pariente, Sheyla Montori, Joan Llach, Alex Bofill, Eduardo Albéniz, Leticia Moreira · 2021 · Biomedicines
  78. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma
    Biyuan Luo, Fang Ma, Hao Liu, Jixiong Hu, Le Rao, Chunying Liu, Yongfang Jiang, Shuyu Kuang-Zeng, Xuan Lin, Chenyang Wang et al. · 2022 · BMC Medicine
  79. Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer
    Daniel C. Bruhm, Dimitrios Mathios, Zachariah H. Foda, Akshaya Vijaya Annapragada, Jamie E. Medina, Vilmos Adleff, Elaine Jiayuee Chiao, Leonardo Ferreira, Stephen Cristiano, James Robert White et al. · 2023 · Nature Genetics
  80. The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
    Ymke van der Pol, Norbert Moldován, Jip Ramaker, Sanne Bootsma, Kristiaan Lenos, Louis Vermeulen, Shahneen Kaur Sandhu, Idris Bahce, Dirk Michiel Pegtel, Stephen Q. Wong et al. · 2023 · Genome biology
  81. Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers
    Jamie E. Medina, Akshaya Vijaya Annapragada, Pien Lof, Sarah B. Short, Adrianna L. Bartolomucci, Dimitrios Mathios, Shashikant Koul, Noushin Niknafs, Michaël Noë, Zachariah H. Foda et al. · 2024 · Cancer Discovery
  82. Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics
    Hua Bao, Shanshan Yang, Xiaoxi Chen, Guangqiang Dong, Yuan Mao, Shuyu Wu, Xi Cheng, Xuxiaochen Wu, Wanxiangfu Tang, Min Wu et al. · 2025 · Nature Medicine
  83. Ultraspecific and Amplification-Free Quantification of Mutant DNA by Single-Molecule Kinetic Fingerprinting
    Stephen L. Hayward, Paul E. Lund, Qing Kang, Alexander E. Johnson-Buck, Muneesh Tewari, Nils G. Walter · 2018 · Journal of the American Chemical Society
  84. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation
    Karen R. Sherwood, Eric T. Weimer · 2018 · Journal of Immunological Methods
  85. A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer
    Andreas Wolfgang Berger, Daniel Schwerdel, Anke Reinacher‐Schick, Waldemar H. Uhl, Hana Algül, Helmut Friess, Klaus‐Peter Janssen, Alexander Otto König, Michael B. Ghadimi, Eike Gallmeier et al. · 2019 · Theranostics
  86. P5 eHealth: An Agenda for the Health Technologies of the Future
    Gabriella Pravettoni, Stefano Triberti · 2019 · Springer eBooks
  87. Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer
    Samantha Torquato, Aparna Pallavajjala, Alexa Goldstein, Patricia Valda Toro, John L. Silberstein, Justin Lee, Mari Nakazawa, Ian G. Waters, David T. W. Chu, Daniel Shinn et al. · 2019 · JCO Precision Oncology
  88. Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
    Mina Gaga, Joanna Chorostowska‐Wynimko, Ildikó Horváth, Martin Carl Tammemägi, David Shitrit, Vered H. Eisenberg, Hao Liang, David Stav, Dan Levy Faber, Maarten A.M. Jansen et al. · 2020 · European Respiratory Journal
  89. Emerging Tests for Noninvasive Colorectal Cancer Screening
    Marina Hanna, Neelendu Dey, William M. Grady · 2022 · Clinical Gastroenterology and Hepatology
  90. Multiplex Digital Methylation‐Specific PCR for Noninvasive Screening of Lung Cancer
    Yang Zhao, Christine M. O’Keefe, Kuangwen Hsieh, Leslie Cope, Sonali C. Joyce, Thomas R. Pisanic, James Gordon Herman, Tza‐Huei Wang · 2023 · Advanced Science
  91. Developing DNA methylation-based diagnostic biomarkers
    Hye-Rim Kim, Xudong Wang, Peng Jin · 2018 · Journal of genetics and genomics/Journal of Genetics and Genomics
  92. Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
    Christopher Blair Douville, Simeon U. Springer, Isaac Kinde, Joshua David Cohen, Ralph H. Hruban, Anne Marie Lennon, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Rachel Karchin · 2018 · Proceedings of the National Academy of Sciences
  93. Update on liquid biopsy in clinical management of non-small cell lung cancer
    Zhen Wu, Zhen Yang, Yu Dai, Qiang Zhu, Liang-An Chen · 2019 · OncoTargets and Therapy
  94. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
    Aitor Rodríguez‐Casanova, Nicolás Costa‐Fraga, Aida Bao‐Caamano, Rafael López‐López, Laura Muinelo‐Romay, Ángel Díaz‐Lagares · 2021 · Frontiers in Cell and Developmental Biology
  95. 33 Unresolved Questions in Nanoscience and Nanotechnology
    Chad Alexander Mirkin, Sarah Hurst Petrosko, Natalie Artzi, Koray Aydın, Austin Biaggne, C. Jeffrey Brinker, Katherine E. Bujold, Y. Charles Cao, Rachel R. Chan, Chaojian Chen et al. · 2025 · ACS Nano
  96. Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer
    Young‐Woo Kim, Young-Ho Kim, Yura Song, Han‐Seong Kim, Hye Won Sim, Shiv Poojan, Bang Wool Eom, Myeong‐Cherl Kook, Jungnam Joo, Kyeong‐Man Hong · 2019 · Experimental & Molecular Medicine
  97. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA
    Tej Deepak Azad, Michael Chuwei Jin, Lydia J. Bernhardt, Chetan Bettegowda · 2020 · Neurosurgical FOCUS
  98. The changing landscape of cancer in the USA — opportunities for advancing prevention and treatment
    Farhad Islami, Rebecca L. Siegel, Ahmedin Jemal · 2020 · Nature Reviews Clinical Oncology
  99. Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges
    Ling‐Yi Kong, Andrew C. Birkeland · 2021 · Cancers
  100. Machine intelligence in non-invasive endocrine cancer diagnostics
    Nicole M. Thomasian, Ihab R. Kamel, Harrison Xiao Bai · 2021 · Nature Reviews Endocrinology